Articles Tagged With:
-
Reteplase is an early prognostic indicator
-
Clot-busters nearly equal, GUSTO report shows
-
Reteplase achieves patency, reduces mortality
-
Profiling moves from defense to offense
-
Clopidogrel pricey, but may edge aspirin
-
Alarmed researchers push for more aggressive treatment and monitoring
-
Medicaid managed care needs different strategies
-
AMA kicks off accreditation program
-
Growth rate of integrated systems shows huge rise in last two years
-
HMOs now cover nearly 30% of insured Americans